Navigation Links
Conseco Reports Preliminary Fourth Quarter and Year-End Results
Date:3/17/2008

p> Total liabilities and shareholders' equity $33,540.5

Note: This preliminary consolidated balance sheet data is subject to

change to reflect any necessary adjustments that are identified before the

Company completes its financial statements and Form 10-K for the year

ended December 31, 2007.

CONSECO, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF OPERATIONS DATA - Preliminary (see note)

(Dollars in millions, except per share data)

Three months ended Year ended

December 31, December 31,

2007 2007

Revenues:

Insurance policy income $814.7 $3,167.3

Net investment income 333.5 1,536.6

Net realized investment losses (36.6) (155.4)

Fee revenue and other income 6.3 23.8

Total revenues 1,117.9 4,572.3

Benefits and expenses:

Insurance policy benefits 804.9 3,453.8

Interest expense 32.5 117.3

Amortization 127.2 454.5

Costs related to a litigation settlement - 64.4

Loss related to an annuity coinsurance

transaction - 76.5

Other operating costs and expenses 156.2 604.1

Total benefits and expenses 1,120.8 4,770.6

Loss before income taxes (2.9) (198.3)

Income tax expense (benefit):

Tax expense (benefit) on period income 1.3 (70.3)

Valuation allowance for de
'/>"/>

SOURCE Conseco, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Conseco to Host Follow-Up Long-Term Care Conference Call
2. Barta joins Conseco as Senior Vice President, Financial Planning & Analysis; Barra named Senior Vice President, Internal Audit; Clarke to head Investor Relations
3. Conseco Completes Divestiture of Old Block of Fixed and Equity-Indexed Annuities
4. Conseco Sets Earnings Release Date
5. Conseco Reports Third Quarter Results
6. Conseco to Implement Systems and Operational Solution From Long Term Care Group
7. Tongson Joins Conseco as Senior Vice President, Corporate Actuarial
8. Hacker Joins Conseco as Senior Vice President and Treasurer
9. Conseco Files to Formally Extend Due Date for Annual Report on Form 10-K to March 17 and Reschedules Earnings Release and Investor Call
10. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
11. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...ey gene that controls specialized brain cells// is...isorders and lead to better treatment of condition..., researchers said Wednesday. The National Univer...iled a new gene that speeds up the growth of the b...
... for longer times than others may be// having deve...ntists. Linda Crowe, associate professor in the co...as State University, said that it’s important for ...ren are having any language delays. Language delay...
...e the age of 80yrs, may remain at a higher risk fr...ndetected for long as well. The report, which was ...bout 75% of the participants of the survey conduct...ertension. The research, which was based on data f...
... Association (IMA) has today warned its members// ...reating or dealing with patients who suffer from b... of the Maoist violence taking place in the neighb...nha of Muzaffarpur district was arrested in May fo...
Other Medicine News:Health News:Language Delays May Not Be Normal In Children 2Health News:Elderly Women Remain At Risk From Hypertension 2
(Date:10/8/2008)...s Research That May Offer New Hope to,Heart Failur...nally, over 3,000 people are,waiting for a heart t...alf,of those will receive a transplant. Now, pione... paving the way for how to treat congestive heart,...ews Release, go to:, http://www.prnewswire.com/mnr...
(Date:10/8/2008)...e TAXUS(R) Element(TM) Platinum Chromium ... 8 /- Boston Scientific,Cor... completed enrollment in,the PERSEUS trial, design...S(R) Element(TM) paclitaxel-eluting coronary stent... 1,500 patients at 100 U.S. and,international cent...
(Date:10/8/2008)...ical improvement in patients with pulmonary a...t options have limited benefit for this debilitati...essel disease, -- Imatinib mesylate, available ...s, known to inhibit protein associated with PAH, ...inib mesylate in PAH in 2009 EAST HANOVER, N...
(Date:10/7/2008)... device for detecting polyps that can be ...Fla., Oct. 7 /- At the American Colle...n Orlando (ACG 2008), renowned,gastroenterologist ...institutional clinical study that evaluated the ef...vice that is designed to improve the ability,of ph...
Breaking Medicine Technology:Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Handbook helps parents deal with childhood infections 1024 1Handbook helps parents deal with childhood infections 1024 2Speed plays crucial role in breaking proteins H bonds 1022 1Speed plays crucial role in breaking proteins H bonds 1022 2Speed plays crucial role in breaking proteins H bonds 1022 3Fuel cells gearing up to power auto industry 1020 1Fuel cells gearing up to power auto industry 1020 2Fuel cells gearing up to power auto industry 1020 3Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths 4974 1Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths 4974 2
...eady being treated with maximally,tolerated lipid-...ons in LDL-C with similar reductions in other athe... NEW ORLEANS, and CARLSBAD, Calif., March 26, 2007...nc. announced,results from its ongoing Phase 2 cli...gous familial hypercholesterolemia (HoFH),present...
... 2007 /PRNewswire-FirstCall/ --,Alfacell Corporati...nstrating the potential of ONCONASE (ranpirnase) f...CLC) were recently,published in Anticancer Researc...ae Lee, Ph.D., at the University of,Pennsylvania, ...xic,RNase, Ranpirnase, on A549 Human Lung Cancer X...
Other Medicine Technology:Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3
Last 3-6 months average refrigeration will prolong life. Pupil gauge printed on penlight 4 1/2" long 1/2" around.
Maxi-Lite diagnostic penlight features a twist-on backswitch.
Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra
Heavy duty, all purpose illuminator available in black only. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentrated l
Medicine Products: